Beneficial Effects of Selective Vitamin D Receptor Activation by Paricalcitol in Chronic Kidney Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|7|703-709

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.7, 2014-06, pp. : 703-709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Paricalcitol versus a Non-Selective Vitamin D Receptor Activator for Secondary Hyperparathyroidism in the UK: A Chronic Kidney Disease Markov Model

By Nuijten Mark  

Clinical Drug Investigation, Vol. 30, Iss. 8, 2010-08 ,pp. : 545-557

Adis International

Access to resources Recommend Favorite

Nonclassical Aspects of Differential Vitamin D Receptor Activation: Implications for Survival in Patients With Chronic Kidney Disease

By Andress Dennis  

Drugs, Vol. 67, Iss. 14, 2007-01 ,pp. : 1999-2012

Adis International

Access to resources Recommend Favorite

Safety and tolerability of paricalcitol in patients with chronic kidney disease

By Dyer Christopher A  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 717-728

Informa Healthcare

Access to resources Recommend Favorite

Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease

By Cheng Steven   Coyne Daniel  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 617-621

Informa Healthcare

Access to resources Recommend Favorite

Vitamin D in Chronic Kidney Disease: New Potential for Intervention

By  

Current Drug Targets, Vol. 12, Iss. 1, 2011-01 ,pp. : 42-53

Bentham Science Publishers

Access to resources Recommend Favorite